Flow VIT® Testkits setzen neuen Standards in der Qualitätskontrolle von Probiotika
Die vermicon AG, ein Pionier auf dem Gebiet der industriellen Mikrobiologie, gibt die Markteinführung der ersten Flow VI…
Die vermicon AG, ein Pionier auf dem Gebiet der industriellen Mikrobiologie, gibt die Markteinführung der ersten Flow VI…
Biotechnology company Mucosis B.V. today announced that it has received an innovation credit line of up to €5 million fr…
Die MorphoSys AG (Frankfurt: MOR; Prime Standard Segment, TecDAX) gab heute eine Kooperation mit dem privat geführten Bi…
Mucosis BV, a clinical-stage Dutch biotechnology company developing innovative mucosal vaccines, today announced that it…
Mucosis B.V., the Dutch clinical-stage biotechnology company developing mucosal vaccines, today announced the appointmen…
Dutch vaccine development company Mucosis B.V. today announced Phase I clinical data providing proof-of-concept that Mim…
Dutch biotechnology company Mucosis B.V. today announced the publication in the peer-reviewed journal Vaccine of preclin…
Dutch biotechnology company Mucosis B.V. today announced that it has appointed professors Jiri Mestecky, M.D., Ph.D.; Wi…
Dutch biotechnology company Mucosis B.V. today announced the appointment of Thomas Johnston as Chief Business Officer. I…
Dutch biotechnology company Mucosis B.V. announced today that Dr. Barry Buckland was elected to its Supervisory Board. D…